1. That's not what progression-free survival means.
I was not pointing to PFS as OS.
2. I don't think AI was mentioned once in this press release.
I did not say it was. I said it was written FOR AI trading algorithms to read and invest on.
4. The paragraph immediately following the one you clipped talks about Overall Response Rate (ORR) and throughout the release they discuss Overall Survival (OS).
Someone noted this was an earlier study. The newest study does not even have data out and yet here we are, investing on a press release.
5. This is not "NOTHING" in statistical terms, but even more so to people with melanoma.
You are talking to someone whose father died of pancreatic cancer. "Pancreatic cancer has a higher mortality rate compared to melanoma, with an estimated 52,740 deaths from pancreatic cancer in 2026, while melanoma has a significantly lower death rate. Additionally, the 5-year relative survival rate for pancreatic cancer is only 13.7%, compared to higher survival rates for melanoma."
What they did for my father was worse than nothing.
Yes every cancer is different, responds to different therapy, and with different survival rates. However, cancer treatment, as a whole, works. Oncologists do not prescribe incredibly intense treatments like chemotherapy out of nowhere. Chemotherapy is often not curative. Instead, it's used to both prolong life and improve quality of life.
Dying from late-stage cancer is often painful and miserable. It might be shocking, but getting just a few more months from chemo can provide a greater quality of life. Keyword can. Every oncologist is different with different recommendations, and they explain the risks very concretely. There is always an option to refuse treatment, but bear in mind it's not just about how quick you die. It's also about how much that dying sucks.